Cargando…
Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial
BACKGROUND: Using kidneys from deceased donors is an available strategy to meet the growing need of grafts. However, higher incidences of delayed graft function (DGF) and acute rejection exert adverse effects on graft outcomes. Since ischemia-reperfusion injury (IRI) and ongoing process of immune re...
Autores principales: | Sun, Qipeng, Hong, Liangqing, Huang, Zhengyu, Na, Ning, Hua, Xuefeng, Peng, Yanwen, Zhao, Ming, Cao, Ronghua, Sun, Qiquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689202/ https://www.ncbi.nlm.nih.gov/pubmed/29145879 http://dx.doi.org/10.1186/s13063-017-2291-y |
Ejemplares similares
-
Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial
por: Sun, Qipeng, et al.
Publicado: (2018) -
Donor plasma mitochondrial DNA is associated with antibody-mediated rejection in renal allograft recipients
por: Han, Fei, et al.
Publicado: (2021) -
Synergistic impact of pre-sensitization and delayed graft function on allograft rejection in deceased donor kidney transplantation
por: Lee, Hanbi, et al.
Publicado: (2021) -
Delayed allogeneic skin graft rejection in CD26-deficient mice
por: Zhao, Xiangli, et al.
Publicado: (2018) -
Duration of delayed graft function and its impact on graft outcomes in deceased donor kidney transplantation
por: Budhiraja, Pooja, et al.
Publicado: (2022)